MindMaze Therapeutics partners with Vibra Healthcare to expand U.S. neurotherapeutics footprint
Miluna Acquisition Corp. Class A
Miluna Acquisition Corp. Class A MMTX | 0.00 |
- MindMaze Therapeutics entered a structured U.S. go-to-market partnership with Vibra Healthcare to expand commercialization of its precision neurotherapeutics platform.
- Collaboration targets large provider groups across inpatient, rehabilitation, outpatient, home care settings.
- Vibra will use its network and market access to support product introductions and broader adoption across U.S. healthcare providers.
- Partnership includes reimbursement strategy work using existing codes plus generation of additional real-world evidence to support uptake.
- Companies signed a term sheet on April 30, 2026, with a definitive agreement in progress; initial joint market-development activities have started.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MindMaze Therapeutics Holding SA published the original content used to generate this news brief via EQS News, a service of EQS Group AG (Ref. ID: corporate_2318380_en), on April 30, 2026, and is solely responsible for the information contained therein.
